Study highlights air pollution as key environmental factor in autism risk

Air pollution is a key environmental risk factor for autism, influencing neurodevelopment through neuroinflammation, oxidative stress, and epigenetic changes.

Renaissance to in-license St Jude’s humanised antibody

Hu14.18 is in development for the treatment of newly diagnosed high-risk neuroblastoma. Credit: Kateryna Kon/Shutterstock.com. Renaissance Pharma has signed an agreement to in-license St Jude

August 1, 2023

HIV cell therapy biotech Addimmune to go public via SPAC merger; WHO names new Covid-19 ‘variant of interest’

Addimmune, a biotech that is working on a cell therapy for HIV, announced Wednesday that it plans to merge with 10X Capital Venture’s SPAC to become

August 11, 2023

Pfizer Australia and BioNTech announce TGA approval for Omicron XBB.1.5-adapted monovalent COVID-19 vaccine

Pfizer Australia and BioNTech SE today announced that the Therapeutic Goods Administration (TGA) have authorised the companies’ XBB.1.5-adapted monovalent COVID-19 vaccine (COMIRNATY® Omicron XBB.1.5) in

October 14, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.